Industry News

Oral Midazolam Proves Most Effective in Pediatric Sedation

Oral Midazolam Proves Most Effective in Pediatric Sedation

23 June 2017

By kindergarten, 40% of children have been diagnosed with early tooth decay or cavities, reports...

eBooks

May 2017

The Dentist’s Guide
To Managing Employees

Download Now!

April 2017

Composite Vs. Porcelain’s:
What You Need To Know

Download Now!

March 2017

Digital Marketing for Dentists

Download Now!

February 2017

Traumatic Dental Injuries: Emergency Assessment And Treatment

Download Now!

Recent Issues

June 2017

Digital Technologies: Changing the Face of Dentistry




READ MORE

May 2017

Solving Aesthetic Challenges From Trauma-Based Injuries




READ MORE

Study Pinpoints Target for TMJD

People with temporomandibular joint disorder may be in luck.

Researchers located a protein that is essential in TMJD pain. This could lead to treatment for this painful disorder.

This information from the Duke Medicine researchers appears in the August issue of PAIN.

There isn’t much information known about what prompts TMJD. The research team pinpointed TRPV4, which is an ion channel protein that enables calcium to enter cells. Its involvement with inflammation and pain was examined.

The research team looked at normal mice and mice that were genetically engineered without TRPV4. Inflammation and pain was then created in the temporomandibular joints, similar to the way it impacts humans.

The mice without TRPV4 had a lower reduction in bite force, indicating they experienced less pain. When there was an increase in TRPV4, the correlation was a larger reduction in bite force.

The research also provided a compound to the normal mice that blocked TRPV4. The ensuing discovery was that inhibiting TRPV4 produced smaller reductions in bite force. The results were comparable to the results from mice without TRPV4.

One bit of information that surprised researchers was the idea that there was comparable bone erosion and inflammation in the jaw tissue for all mice. The amount of TRPV4 did not impact this. Essentially the damage is the same but the pain level varies.

Based on this study, it’s possible the TRPV4 could be utilized to develop new treatment for TMJ issues.

TMJD is the most common form of oral and facial pain and afflicts more than 10 million Americans. The chronic disorder results in severe pain that stems from chewing or biting down. There are no full-proof treatments.

The Wednesday Watch

Exclusive Interview: Patient Education and GentleWave

Exclusive Interview: Patient Education and GentleWave

21 June 2017

Patients are becoming more educated, as a world of information is readily available at our...

Technique of the Week

e-Prescribing with XLDent

e-Prescribing with XLDent

29 March 2017

Drs. David Andersen and Lora Nelson explain how easy e-Prescribing...

Technology Today

Show Me the Way

Show Me the Way

02 May 2017

This year’s International Dental Show did not disappoint: 155,000 participants from 157 countries attended,...

Implants Today

Narrow-Body  Dental Implants

Narrow-Body Dental Implants

02 May 2017

As the multibillion-dollar market for dental implants grows, many new companies are entering the...

Quick Technique

Dentsply Sirona’s recently introduced Aquasil Ultra+ Smart Wetting Impression Material…
Figure 1. Almost everyone would love to have a whiter…
INTRODUCTION Today’s core build-up materials have been part of the…
The canal system within teeth is a complex array of…
Dentsply Sirona’s New Self-Adhesive Resin Cement Features a Wide Tack-Cure…
Introduction In this article, I describe a technique for cementation…
The Uveneer System (Ultradent Products) is a clear template kit…
Patients often avoid dental care due to the perceived pain…


Dentistry Today is The Nation's Leading Clinical News Magazine for Dentists. Here you can get the latest dental news from the whole world quickly.